{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:43:38Z","timestamp":1789879418463,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2012.07.093","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T10:49:57Z","timestamp":1386758997000},"page":"F60-F72","source":"Crossref","is-referenced-by-count":38,"special_numbering":"S5","title":["Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in Sub-Saharan Africa"],"prefix":"10.1016","volume":"31","author":[{"given":"Jane J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Mutyaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.093_bib0005","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer incidence and mortality worldwide. IARC CancerBase No. 10 [Internet]. Lyon, France: IARC; 2010. Available at: http:\/\/globocan.iarc.fr (last accessed July 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0010","unstructured":"WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Africa. Summary Report 2010. Available at: www.hpvcentre.net (last accessed December 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0015","unstructured":"Department of Health, Republic of South Africa. National Guideline on Cervical Cancer Screening Programme. Available at: http:\/\/www.doh.gov.za\/docs\/factsheets\/guidelines\/cancer.pdf (last accessed December 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0020","first-page":"398","article-title":"Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu","volume":"370","author":"Sankaranarayanan","year":"2007","journal-title":"India: a cluster-randomised trial, Lancet"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0025","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.093_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpobgyn.2011.08.003","article-title":"Visual inspection methods for cervical cancer prevention","volume":"26","author":"Sankaranarayanan","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0035","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Alliance for Cervical Cancer Prevention Cost Working Group, Cost-effectiveness of cervical cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.093_bib0040","doi-asserted-by":"crossref","first-page":"e1001032","DOI":"10.1371\/journal.pmed.1001032","article-title":"Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia","volume":"8","author":"Mwanahamuntu","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0280","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/ijc.26211","article-title":"The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies","volume":"130","author":"Gage","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0050","unstructured":"Kagire E. First Lady to launch anti-cervical cancer campaign. The New Times April 26, 2011. Available at: http:\/\/www.newtimes.co.rw\/index.php?issue=14607&article=40560 (last accessed December 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0055","unstructured":"GAVI Alliance Countries eligible for support. Available at: http:\/\/www.gavialliance.org\/support\/apply\/countries-eligible-for-support\/ (last accessed July 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0060","unstructured":"World Bank World Development Indicators. Available at: http:\/\/data.worldbank.org\/data-catalog\/world-development-indicators (last accessed December 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0065","unstructured":"World Health Organization (WHO). Statistical Information System: CHOICE (CHOosing Interventions that are Cost Effective). Available at: http:\/\/www.who.int\/choice\/en\/ (last accessed December 2011)."},{"issue":"24","key":"10.1016\/j.vaccine.2012.07.093_bib0070","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.285.24.3107","article-title":"Policy analysis of cervical cancer screening strategies in low-resource settings - Clinical benefits and cost-effectiveness","volume":"285","author":"Goldie","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2012.07.093_bib0075","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/ijc.26269","article-title":"Health and economic impact of HPV 16\/18 vaccination and cervical cancer screening in Eastern Africa","volume":"130","author":"Campos","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0080","unstructured":"Disease Control Priorities Project (DCPP). Available at: http:\/\/www.dcp2.org\/main\/Home.html (last accessed April 2008)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0085","series-title":"Methods for the economic evaluation of health care programs.","year":"2005"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0090","unstructured":"World Health Organization (WHO). Macroeconomics and health: investing in health for economic development: report of the commission on macroeconomics and health. Geneva:World Health Organization, 2001."},{"issue":"32","key":"10.1016\/j.vaccine.2012.07.093_bib0095","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"S12","key":"10.1016\/j.vaccine.2012.07.093_bib0100","doi-asserted-by":"crossref","first-page":"M17","DOI":"10.1016\/j.vaccine.2008.06.018","article-title":"Mathematical models of cervical cancer prevention in the Asia Pacific region","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"S11","key":"10.1016\/j.vaccine.2012.07.093_bib0105","doi-asserted-by":"crossref","first-page":"L59","DOI":"10.1016\/j.vaccine.2008.05.063","article-title":"Mathematical models of cervical cancer prevention in Latin America and the Caribbean","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0110","unstructured":"United Nations (UN), Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2008 Revision. CD-ROM Edition - Extended Dataset (United Nations publications, Sales No. E.05.XIII.12)."},{"issue":"11","key":"10.1016\/j.vaccine.2012.07.093_bib0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"on behalf of the Retrospective International Survey and HPV Time Trends Study Group, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0120","unstructured":"World Health Organization (WHO). Life tables for WHO member states: 2009. Available at: http:\/\/www.who.int\/healthinfo\/statistics\/mortality_life_tables\/en\/ (last accessed July 26, 2011)."},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.093_bib0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.bjc.6604462","article-title":"Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India","volume":"99","author":"Diaz","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0130","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","author":"Goldie","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multi-parameter calibration of a natural history model of cervical cancer","volume":"166","author":"Kim","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"16","key":"10.1016\/j.vaccine.2012.07.093_bib0140","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.ejca.2010.06.016","article-title":"Cost-effectiveness of human papillomavirus vaccination and screening in Spain","volume":"46","author":"Diaz","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.093_bib0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1471-0528.2011.02974.x","article-title":"Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand","volume":"119","author":"Sharma","year":"2011","journal-title":"BJOG"},{"issue":"32","key":"10.1016\/j.vaccine.2012.07.093_bib0150","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/j.vaccine.2008.05.038","article-title":"Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2012.07.093_bib0155","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/S0264-410X(02)00296-7","article-title":"Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis","volume":"20","author":"Acharya","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0160","series-title":"Guidelines for estimating costs of introducing new vaccines into the national immunization system","author":"Kou","year":"2002"},{"issue":"9","key":"10.1016\/j.vaccine.2012.07.093_bib0165","first-page":"676","article-title":"Variation in the costs of delivering routine immunization services in Peru","volume":"82","author":"Walker","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2012.07.093_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2471\/BLT.07.045096","article-title":"Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006\u20132015","volume":"86","author":"Wolfson","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1478-7547-4-13","article-title":"Estimating the cost of cervical cancer screening in five developing countries","volume":"4","author":"Goldhaber-Fiebert","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0180","unstructured":"World Health Organization (WHO). Alphabetical list of WHO member states. Available at: http:\/\/www.who.int\/choice\/demography\/by_country\/en\/index.html (last accessed July 25, 2011)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0185","unstructured":"Central Intelligence Agency (CIA). The World Factbook. Available at: https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/ (last accessed June 2012)."},{"issue":"19","key":"10.1016\/j.vaccine.2012.07.093_bib0190","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"CVT Vaccine Group, Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.vaccine.2012.07.093_bib0195","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0200","doi-asserted-by":"crossref","first-page":"b3884","DOI":"10.1136\/bmj.b3884","article-title":"Cost-effectiveness analysis of including boys in a human papillomavirus (HPV) vaccination programme in the United States","volume":"339","author":"Kim","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0205","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sti.2004.011858","article-title":"Diagnostic accuracy of self-collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis","volume":"81","author":"Ogilvie","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0215","unstructured":"World Health Organization (WHO). Global health expenditures database, 2009. Available at: http:\/\/apps.who.int\/nha\/database\/StandardReport.aspx?ID=REPORT_6_REGIONAL_AVERAGES# (last accessed December 2011)."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2012.07.093_bib0220","article-title":"Modeling preventative strategies in developed countries","volume":"31","author":"Canfell","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0225","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0230","first-page":"833","article-title":"Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves","volume":"85","author":"Kim","year":"2007","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0235","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2471\/BLT.06.034686","article-title":"Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya","volume":"85","author":"Akumu","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2334-11-174","article-title":"Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0245","unstructured":"UNAIDS: Uganda Available at: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/uganda\/ (last accessed on May 2012)."},{"key":"10.1016\/j.vaccine.2012.07.093_bib0250","unstructured":"UNAIDS: South Africa Available at: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica\/ (last accessed on May 2012)."},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.093_bib0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0b013e3181de8d26","article-title":"Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old","volume":"55","author":"Levin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0260","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0b013e3283377973","article-title":"The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe","volume":"24","author":"Averbach","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0265","doi-asserted-by":"crossref","first-page":"e10094","DOI":"10.1371\/journal.pone.0010094","article-title":"Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections","volume":"5","author":"Smith-McCune","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0270","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/QAD.0b013e32833cbb71","article-title":"HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda","volume":"24","author":"Veldhuijzen","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2012.07.093_bib0275","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/QAD.0b013e32833e163e","article-title":"Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women","volume":"24","author":"Kuhn","year":"2010","journal-title":"AIDS"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:02:10Z","timestamp":1538971330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":55,"alternative-id":["S0264410X13005197"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}